The Interplay between T Cells and Cancer: The Basis of Immunotherapy

Area of Science:

• Immunology
• Oncology
• Biotechnology

Background:

• Immunotherapy has revolutionized cancer treatment over the last decade.
• Immune checkpoint inhibitors and engineered T cell therapies (CAR T, TCR T) have shown significant clinical success.

Purpose of the Study:

• To review the role of T cells in cancer immunity.
• To explore current challenges in cancer immunotherapy.
• To highlight recent advancements in T-cell-based cancer treatments.

Main Methods:

• Literature review of immunotherapy mechanisms and challenges.
• Analysis of T cell exhaustion, transcriptional, and epigenetic changes.
• Examination of tumor microenvironment and cancer cell-intrinsic factors.

Main Results:

• T cells are crucial for anti-cancer defense.
• Challenges include patient unresponsiveness to checkpoint inhibitors and limited CAR T cell efficacy in solid tumors.
• T cell exhaustion and immunosuppressive tumor microenvironments hinder treatment efficacy.

Conclusions:

• Despite advancements, significant hurdles remain in optimizing T-cell-based cancer immunotherapies.
• Addressing T cell dysfunction and the tumor microenvironment is critical for future therapeutic development.